Question follow-through · 4457
Trastuzumab Deruxtecan: Prices
To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to negotiate with pharmaceutical companies to lower the unit cost of the drug Enhertu.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 29 May 2026
- Target answer date
- 2 Jun 2026
- Answer
- 9 Jun 2026 · 11 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- ME/CFS: Health Services · 28 Aug 2026
- Postpartum Haemorrhage: Hampstead and Highgate · 28 Aug 2026
- Postpartum Haemorrhage: Hampstead and Highgate · 28 Aug 2026
- ME/CFS: Health Services · 28 Aug 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
29 May 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to negotiate with pharmaceutical companies to lower the unit cost of the drug Enhertu.
2 Jun 2026
Target answer date
Date supplied by the official written-questions record.
9 Jun 2026
Answer published
Ministers met with the manufacturers of Enhertu, AstraZeneca and Daiichi Sankyo, in November 2024 to encourage them to engage constructively with NHS England and the National Institute for Health and Care Excellence (NICE) to reach a commercial agreement ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
ME/CFS: Health Services
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what guidance her Department has issued to Integrated Care Boards on commissioning services for patients with very severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Postpartum Haemorrhage: Hampstead and Highgate
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what steps she is taking to improve outcomes for women in Hampstead and Highgate with postpartum haemorrhage and ensure they have access to appropriate and innovative treatments.
Postpartum Haemorrhage: Hampstead and Highgate
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what steps she is taking to (a) improve outcomes for women in Hampstead and Highgate constituency with postpartum haemorrhage and (b) ensure access to appropriate and innovative treatments.
ME/CFS: Health Services
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what guidance her Department has issued to Integrated Care Boards on commissioning services for patients with very severe myalgic encephalomyelitis/chronic fatigue syndrome.